These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34888360)

  • 1. Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis.
    Li D; Li Y; Lin M; Zhang W; Fu G; Chen Z; Jin C; Zhang W
    Front Cardiovasc Med; 2021; 8():746988. PubMed ID: 34888360
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bilirubin on perioperative myocardial infarction and its long-term prognosis in patients undergoing percutaneous coronary intervention.
    Li Y; Li DB; Zhao LD; Lv QB; Wang Y; Ren YF; Zhang WB
    World J Clin Cases; 2022 Feb; 10(6):1775-1786. PubMed ID: 35317137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
    Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 7. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
    Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
    Gregson J; Stone GW; Ben-Yehuda O; Redfors B; Kandzari DE; Morice MC; Leon MB; Kosmidou I; Lembo NJ; Brown WM; Karmpaliotis D; Banning AP; Pomar J; Sabaté M; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Pocock SJ
    J Am Coll Cardiol; 2020 Oct; 76(14):1609-1621. PubMed ID: 33004126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revascularization Versus Medical Therapy in Patients Aged 80 Years and Older with Acute Myocardial Infarction.
    Phan DQ; Rostomian AH; Schweis F; Chung J; Lin B; Zadegan R; Lee MS
    J Am Geriatr Soc; 2020 Nov; 68(11):2525-2533. PubMed ID: 32789854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.